FDA
approval
· 2022-11-28
FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Amneal Pharmaceuticals LLC)
Summary
FDA approved the original application for Prochlorperazine Edisylate as a generic antiemetic indicated for relief of nausea and vomiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)